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Alzheimer’s disease (AD) is the most common form of dementia, affecting
millions of people and currently lacking available disease-modifying treat-
ments. Appropriate disease models are necessary to investigate disease
mechanisms and potential treatments. Drosophila melanogaster models of
AD include the Ab fly model and the AbPP-BACE1 fly model. In the Ab
fly model, the Ab peptide is fused to a secretion sequence and directly
overexpressed. In the AbPP-BACE1 model, human AbPP and human
BACE1 are expressed in the fly, resulting in in vivo production of Ab pep-
tides and other AbPP cleavage products. Although these two models have
been used for almost two decades, the underlying mechanisms resulting in
neurodegeneration are not yet clearly understood. In this study, we have
characterized toxic mechanisms in these two AD fly models. We detected
neuronal cell death and increased protein carbonylation (indicative of
oxidative stress) in both AD fly models. In the Ab fly model, this correlates
with high Ab1–42 levels and down-regulation of the levels of mRNA encod-
ing lysosomal-associated membrane protein 1, lamp1 (a lysosomal marker),
while in the AbPP-BACE1 fly model, neuronal cell death correlates with
low Ab1–42 levels, up-regulation of lamp1 mRNA levels and increased levels
of C-terminal fragments. In addition, a significant amount of AbPP/Ab
antibody (4G8)-positive species, located close to the endosomal marker
rab5, was detected in the AbPP-BACE1 model. Taken together, this study
highlights the similarities and differences in the toxic mechanisms which
result in neuronal death in two different AD fly models. Such information
is important to consider when utilizing these models to study AD patho-
genesis or screening for potential treatments.
Alzheimer’s disease (AD) is a neurodegenerative disor-
der that leads to progressive cognitive decline. It is the
most prevalent form of dementia, affecting 11% of the
population over the age of 65, and it is the sixth
leading cause of death in the United States [1]. A
hallmark of the disease is the aggregation of the amy-
loid b (Ab) peptide into fibrillar deposits known as
amyloid plaques [2]. However, research in the AD field
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points towards the soluble Ab species, rather than the
fibrillar deposits, as playing a key pathogenic role in
the disease [3]. The generation of Ab peptides occurs
through proteolytic processing of the transmembrane
Ab precursor protein (AbPP) by the b-site AbPP-
cleaving enzyme (BACE1) followed by the intramem-
branous enzyme complex c-secretase [4–6]. Depending
on the site of cleavage, different-sized Ab peptides are
generated, with Ab1–40 and Ab1–42 being the most fre-
quent isoforms. Ab1–42 has a higher propensity to form
prefibrillar aggregates compared to Ab1–40, and it has
also been reported to be more toxic than Ab1–40 [7].
The Ab peptides are not the only cleavage products
from AbPP processing; when AbPP is first cleaved by
BACE1, a C-terminal fragment (CTF) consisting of 99
amino acids (C99) is produced. The level of C99 is
higher in AD brains, and C99 from BACE1 cleavage
of AbPP has been shown to overactivate rab5, leading
to endosomal dysfunction [8].
To increase the understanding of the different path-
ways and mechanisms involved in AD, appropriate
disease models are necessary. Drosophila melanogaster,
the fruit fly, is one of the most well-studied eukary-
otes. The entire genome of the fruit fly was
sequenced in 2000, and around 76% of human dis-
ease genes have homologues in the fly genome [9].
For almost two decades, the fly has been used to
study AD and Ab proteotoxicity. The more com-
monly used Ab fly model has the gene encoding the
Ab1–42 sequence cloned into the fly genome; the pep-
tide is expressed fused to a signal sequence, resulting
in secretion of the peptide to the extracellular space
[10–12]. In the other models, human AbPP is co-ex-
pressed with human BACE1 allowing the production
of C99 and different isoforms of the Ab peptide (in-
cluding post-translationally modified Ab variants)
through the processing of human AbPP by human
BACE1 and by endogenous fly c-secretase (the
AbPP-BACE1 fly model) [13,14]. AD fly models have
been frequently used during the last two decades to
investigate Ab toxicity, cell-specific vulnerability and
aggregation [15–22]. However, potential differences in
the toxic mechanisms between the two different AD
fly models have not been thoroughly investigated.
Recently, we published a study where the toxic effects
in these two AD fly models were studied in parallel
[14]. We found that the proteotoxic effect, defined as
the reduction in median survival time divided by total
amount of Ab1–42, is considerably higher for the
AbPP-BACE1 flies compared to the Ab1–42 flies,
implying that the mechanisms of toxicity are different
between these two AD fly models. In this study, we
further investigate toxicity and disease mechanisms
relevant in the context of AD for the Ab1–42 and
AbPP-BACE1 flies by performing immunohistological
and biochemical assays to probe: (a) the extent of
neuronal death and protein carbonylation, (b) the
gene expression level and distribution of markers of
early endosomes and lysosomes and (c) the location
of AbPP (and its cleavage products including Ab1–42)
and early endosomes and lysosomes in the fly CNS.
Here, we present data which reveal that neuronal cell
death is present in both AD fly models. The cell
death was significantly higher in the Ab1–42 flies com-
pared to the AbPP-BACE1 flies. However, the extent
of cell death found in the AbPP-BACE1 flies was
remarkably high considering the low level of Ab1–42
peptide detected in these flies (about 200 times lower
than the Ab1–42 flies). Therefore, to probe the patho-
logical processes contributing to neuronal cell death
in these two fly models, two cellular events that have
been closely connected to AD, protein carbonylation
and changes in the endo-lysosomal system machinery
were investigated [8,23–26].
Results
In both AD fly models, apoptosis leads to
neuronal death
Alzheimer’s disease is the most common neurodegener-
ative disease; thus, neuronal cell death is a crucial fea-
ture of any potential AD animal model. By using the
terminal deoxynucleotidyl transferase dUTP nick end
labelling (TUNEL) assay, the presence of apoptotic
cells in brain sections from Drosophila was investigated
for control w1118 (only expressing Gal4), AbPP (hu-
man AbPP695), Ab1–42 9 2 (fly line with two copies of
Ab1–42) and AbPP-BACE1 (human AbPP695 and
human BACE1) flies (Fig. 1A). Flies were analysed at
day 21, a time point corresponding to the median sur-
vival time previously observed for AbPP-BACE1 flies
[14]. The majority of all TUNEL-positive cells were
observed in the medulla and the lamina (Fig. 1B). By
scoring the presence of TUNEL-positive cells in a
blind fashion, a significant increase in the number of
TUNEL-positive cells was observed for both the
Ab1–42 9 2 (P ≤ 0.0001) and the AbPP-BACE1
(P ≤ 0.05) flies relative to their control flies (w1118 and
AbPP flies, respectively), demonstrating the presence
of apoptotic cells in both model systems (Fig. 1C).
The increase in TUNEL-positive cells was significantly
higher (P ≤ 0.05) for the Ab1–42 9 2 flies compared to
the AbPP-BACE1 flies, revealing a higher level of neu-
ronal apoptosis in the Ab1–42 9 2 flies at the selected
time point.
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Fig. 1. Both AD fly models demonstrate apoptotic cell death and protein carbonylation. (A) Apoptotic cells in control, Ab1–42 9 2, AbPP and
AbP-BACE1 flies at day 21 identified by TUNEL (green) staining. Image inset highlights TUNEL-positive cells. Micrographs were taken at
409 magnification, scale bar = 50 lm, n = 4–5 brains. DAPI was used to visualize cell nuclei (blue). (B) Schematic image of a fly brain
where the red box indicates which areas were analysed for TUNEL-positive cells; this corresponds to the medulla and the lamina. (C)
Nonbiased scoring of the presence of TUNEL-positive cells, n = 4–5, data represented as mean  SD. * represents P ≤ 0.05 and ****
represents P ≤ 0.0001 as determined by a one-way ANOVA followed by Tukey’s post hoc test. (D) Quantification of Ab1–42 in the different
fly genotypes at day 21, n = 3 (20 flies in each repeat). Data represented as mean  SD. (E) Representative western blot showing the
bands corresponding to full-length AbPP and the CTFs for AbPP and AbPP-BACE1 flies at day 21. Tubulin is used as a protein loading
control, n = 4 (20 flies in each repeat). (F) Densitometry for full-length AbPP and CTFs correlated to tubulin, data represented as
mean  SEM (n = 4). * represents P ≤ 0.05 as determined by the Mann–Whitney U test. (G) Representative immunoblot showing the total
protein carbonylation in control, Ab1–42 9 2, AbPP and AbPP-BACE1 flies at day 21, n = 4 (20 flies in each repeat). Nonspecific band in
nonderivatized negative control sample found in all sample preparations was used as a protein loading control.
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The Ab1–42 load is significantly higher in the
Ab1–42 3 2 flies compared to the AbPP-BACE1 flies
As the Ab1–42 peptide is closely linked to AD and neu-
rodegeneration [24,27,28], the total level of Ab1–42 pre-
sent in the different fly genotypes was determined
(Fig. 1D). The highest level of Ab1–42 was detected in
the Ab1–42 9 2 flies (40  2.6 pg per fly), which was
approximately 200 times higher than the level detected
in the AbPP-BACE1 flies (0.20  0.04 pg per fly).
Thus, a significantly higher level of Ab1–42 is present in
the Ab1–42 9 2 flies compared to the AbPP-BACE1
flies and this correlates with the higher level of neu-
ronal apoptosis observed in the Ab1–42 9 2 flies com-
pared to the AbPP-BACE1 flies.
Increased level of the C-terminal fragments in the
AbPP-BACE1 flies compared to the AbPP flies
After the first cleavage of full-length AbPP by
BACE1 or by fly intrinsic a-secretase, two different
CTFs are produced (C99 and C83, respectively), and
C99 from BACE1 cleavage of AbPP may be involved
in neurotoxic events [8]. To specifically investigate the
presence of full-length AbPP and CTFs in the AbPP
flies and the AbPP-BACE1 flies, a western blot was
performed using a C-terminal AbPP antibody from
Sigma-Aldrich (St. Louis, MO, USA) (Fig. 1E –
entire blot in Fig. S1). The result revealed a signifi-
cant decrease in the level of full-length AbPP and a
significant increase in the level of CTFs (C99) in the
AbPP-BACE1 flies compared to the AbPP flies
(Fig. 1F).
Increased protein carbonylation in both AD fly
models
Mitochondrial dysfunction and subsequent increased
oxidative stress have been connected with neurodegen-
eration and AD [23]. Protein carbonylation, an indica-
tor of oxidative stress [29], was investigated in the fly
models. Protein carbonylation was detected in all four
genotypes (Fig. 1G); however, an increase in protein
carbonylation was detected for both the Ab1–42 9 2
flies and the AbPP-BACE1 flies compared to their
respective controls (w1118 and AbPP flies). Interest-
ingly, the proteins that were carbonylated differed
between the Ab1–42 9 2 and AbPP-BACE1 flies. In the
Ab1–42 9 2 flies, two carbonylated protein bands were
detected, one band above 188 kDa and one band
around 62 kDa. These two bands were essentially
absent in the AbPP-BACE1 flies, and the carbonyla-
tion detected in the AbPP-BACE1 flies occurred for
proteins with lower molecular weights compared to the
Ab1–42 9 2 flies (< 62 kDa).
Distribution of early endosomes and lysosomes
in the two AD fly models
Endosomal and lysosomal dysfunctions can be
observed in the early stages of AD, and with time, it
progresses to a widespread failure of intraneuronal
waste clearance and eventually neuronal death
[26,30–32]. To investigate the distribution of early
endosomes and lysosomes in the AD flies, Drosophila
brain sections for control w1118, AbPP, Ab1–42 9 2
and AbPP-BACE1 flies were stained with a Droso-
phila anti-rab5 antibody, investigating the presence of
early endosomes (Fig. 2A), or with a Drosophila anti-
LAMP1 antibody, investigating the presence of lyso-
somes (Fig. 2B). The area of the brain analysed is
the same as for the TUNEL analysis, highlighted in
Fig. 1B.
The immunohistochemistry analysis showed that
early endosomes were located perinuclear as well as
separated from the cell bodies in all fly genotypes
(Fig. 2A). Staining control w1118 flies with a Drosophila
anti-axon antibody reveals a network of axons sepa-
rated from the cell bodies (Fig. 2C). This staining pat-
tern of axons is very similar to the staining pattern of
early endosomes separated from the cell nuclei. Thus,
the early endosomes detected separated from the cell
bodies are likely located in this network of axons, indi-
cating that early endosomes are present both around
the cell nuclei, in the cell body and in the axons of the
fly neurons. No significant differences in the rab5
mRNA levels were observed between the four geno-
types (Fig. 2D).
The immunohistochemistry analysis of the distribu-
tion of lysosomes showed both perinuclear staining
and staining separated from the cell bodies in all fly
genotypes (Fig. 2B). Looking at the mRNA level of
the lysosomal marker, LAMP1, a small but significant
(P ≤ 0.05) up-regulation of lamp1 was detected for the
AbPP-BACE1 flies compared to AbPP flies while a
small but significant (P ≤ 0.05) down-regulation was
detected for lamp1 mRNA in the Ab1–42 9 2 flies com-
pared to control w1118 flies (Fig. 2E).
Taken together, the distribution of endosomes and
lysosomes was found both perinuclear and separated
from the cell bodies. No differences in the mRNA
levels of the rab5 endosomal marker were detected,
but an up-regulation of lamp1 was observed in the
AbPP-BACE1 flies compared to AbPP flies, whereas
there was a down-regulation in lamp1 mRNA in the
Ab1–42 9 2 flies compared to control w
1118 flies.
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The AbPP/Ab antibody 4G8 signal occurs in close
vicinity to the staining pattern of early
endosomes in the AbPP-BACE1 flies
To compare the location of AbPP and/or Ab with early
endosomes, Drosophila brain sections were costained
with the Drosophila anti-rab5 antibody and the AbPP/
Ab antibody 4G8 (which is known to react to both the
Ab peptide and full-length AbPP [33]) or the N-terminal
Ab antibody from Mabtech (Nacka Strand, Sweden)
(Fig. 3). The area of the brain analysed is the same as
for the TUNEL analysis, highlighted in Fig. 1B. Control
w1118 flies showed no 4G8 or Mabtech staining (Fig. 3A,
E). In the Ab1–42 9 2 flies, the 4G8 and Mabtech signals
were located around the cell nuclei (Fig. 3B,F). In the
AbPP flies, a 4G8 signal was detected in the axons, sepa-
rated from the cell bodies and in close vicinity to the
staining pattern of early endosomes (Fig. 3C). No Mab-
tech signal was detected in the AbPP flies (Fig. 3G). In
the AbPP-BACE1 flies, an intense 4G8 signal was pre-
sent both around the cell nuclei and in the axons, in
close vicinity to the staining pattern of early endosomes
(Fig. 3D). A Mabtech signal was observed in the AbPP-
BACE1 flies around the cell nuclei (Fig. 3H).
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Fig. 2. Lysosomal alterations in AD fly models. (A) Drosophila brain sections, day 21, of control, Ab1–42 9 2, AbPP and AbPP-BACE1 flies
were stained with a Drosophila anti-rab5 antibody (marker for early endosomes, green) or (B) with a Drosophila anti-LAMP1 antibody
(marker for lysosomes, green). DAPI (blue) was used to visualize cell nuclei. White arrowheads indicate perinuclear rab5 staining in
Ab1–42 9 2 and AbPP-BACE1 flies in panel (A). Micrographs were taken at 1009 magnification, scale bar = 20 lm and n = 6 in (A) and (B).
(C) Drosophila brain sections of control flies stained with a Drosophila anti-axon antibody, n = 3. mRNA levels of rab5 (D) and lamp1 (E)
were analysed, n = 3 (20 flies in each repeat). * represent P ≤ 0.05 as determined by Wilcoxon signed-rank test. The final data presented
as 2DDCmin to 2DDCmax with SE.
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Next, Drosophila brain sections were costained with
the Drosophila anti-LAMP1 antibody and 4G8 or the
Mabtech antibody to compare the locations of AbPP
and/or Ab and lysosomes in the fly brain (Fig. 4).
Control w1118 flies showed no 4G8 or Mabtech stain-
ing (Fig. 4A,E). As observed in the previous staining
(Fig. 3B,F), the 4G8 and Mabtech signals were located
around the cell nuclei in the Ab1–42 9 2 flies (Fig. 4B,
F). In the AbPP flies, a 4G8 signal was located in the
axons, separated from the cell bodies, but no lysosome
staining occurred at this location (Fig. 4C). No Mab-
tech signal was detected in the AbPP flies (Fig. 4G). In
the AbPP-BACE1 flies, an intense 4G8 signal was pre-
sent around the cell nuclei and in the axons but the
signal did not coincide with the lysosome staining
(Fig. 4D). A Mabtech signal was observed in the
AbPP-BACE1 flies around the cell nuclei (Fig. 4H).
Taken together, a signal from the 4G8 antibody was
detected around the cell nuclei for the Ab1–42 9 2 flies,
in the axons for the AbPP flies and in both places for
the AbPP-BACE1 flies. The staining pattern of 4G8
and endosomes coincided in the AbPP flies and the
AbPP-BACE1 flies, while the 4G8 signal in the
Ab1–42 9 2 did not coincide with the endosome signal.
The staining pattern of lysosomes did not coincide
with the 4G8 signal in any of the flies. Signals from
the Mabtech antibody were observed around the cell
nuclei for the Ab1–42 9 2 and for the AbPP-BACE1
flies but did not coincide with the lysosome or endo-
some signals.
Discussion
Understanding the underlying mechanisms of AD toxi-
city is a key requirement to developing mechanism-
based therapeutic strategies, and the use of Drosophila
to investigate the pathogenesis of AD has allowed sci-
entists to achieve important goals in this research field
[34]. AD research using Drosophila frequently implies
one of two approaches; either the Ab peptides are
fused to a secretion sequence and directly produced
from transgenes (the Ab fly model) or the Ab peptides
are produced by the processing of human AbPP (the
AbPP-BACE1 fly model) [10,14,35–38]. In this paper,
we have looked, in detail, at the pathways leading to
toxicity within the two AD fly models and have high-
lighted differences in the underlying mechanisms of the
AD-related toxicity observed in these systems.
In our previous study, longevity and locomotor
analyses showed significant toxic effects for both the
Ab42 flies and AbPP-BACE1 flies [14]. The time frame
selected for this study was 21 days, corresponding to
the median survival time for the AbPP-BACE1 flies.
Around this age, the flies in both AD models start to
A B C D
E F G H
Fig. 3. AbPP/Ab antibody 4G8 signal occurs in the vicinity of early endosomes in the AbPP-BACE1 flies. Drosophila brain sections (day 21)
of control, Ab1–42 9 2, AbPP and AbPP-BACE1 flies costained with a Drosophila anti-rab5 antibody (green; early endosomes), and the AbPP/
Ab antibody 4G8 (red) (A–D) or the N-terminal Ab antibody from Mabtech (red) (E–H). DAPI was used to visualize cell nuclei (blue).
Micrographs were taken at 1009 magnification, scale bar = 20 lm and n = 6.
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display dysfunctional locomotor behaviour. Studies
have shown that dysfunctional locomotor behaviour in
Drosophila is associated with neurodegeneration [39].
The results from the TUNEL assay revealed the pres-
ence of apoptotic cells in both AD models albeit to a
higher extent in the Ab1–42 9 2 flies compared to the
AbPP-BACE1 flies. This difference in apoptotic cell
death was found to correlate with the dramatically
higher level of Ab1–42 present in the Ab1–42 9 2 flies,
where 200 times more Ab1–42 accumulated as com-
pared to the AbPP-BACE1 flies at day 21. This differ-
ence in the Ab1–42 level is in concordance with
previous data demonstrating a ratio of 1:40 of the
Ab1–42 level between the AbPP-BACE1 and the
Ab1–42 9 2 flies at day 7 [14]. Hence, Ab1–42 accumu-
lates to an even higher degree in the Ab1–42 9 2 flies
compared to the AbPP-BACE1 flies with subsequent
ageing.
The Ab1–42 peptide is more hydrophobic than the
shorter isoforms and is therefore more prone to aggre-
gating and forming toxic species [7,40,41]. It can form
large amyloid aggregates which can sequester other
proteins, leading to toxicity due to loss of function
[42]. Ab1–42 oligomers of different sizes have been
found to impair memory in AD rodent models and the
peptide itself has been shown to interact with other
proteins, such as cell surface receptors, leading to
downstream signalling which may contribute to neu-
rodegeneration [43–46]. Thus, it is likely that the neu-
ronal death observed in the Ab1–42 9 2 flies is due to
high accumulation of toxic Ab1–42 species. Indeed, this
is supported by several other studies where high levels
of Ab1–42 have been shown to cause neurodegeneration
in Drosophila models of AD [12,47,48].
An early event in AD pathology is an increase in
oxidative stress, which can be observed in patients
with mild cognitive impairment (MCI) before any sig-
nificant increase in amyloid plaques or neurofibrillary
tangles can be detected [23]. Oxidative stress is an indi-
cator of mitochondrial dysfunction, causing a rise in
reactive oxygen species which results in an increase in
protein carbonylation [29]. Interestingly, both the
Ab1–42 9 2 flies and the AbPP-BACE1 flies showed an
increase in protein carbonylation compared to control
w1118 and AbPP flies. This implies that oxidative stress
is a possible contributor to neurodegeneration in both
AD fly models. The Ab peptide has been shown to
impair degradation of mitochondrial proteins and to
change mitochondrial membrane potential, which may
trigger the release of cytochrome c and thus induce
apoptosis [25,49,50]. Therefore, a noticeable contribu-
tion to the neuronal death in the AbPP-BACE1 flies
A B C D
E F G H
Fig. 4. Signals for the AbPP/Ab antibody 4G8 nor Ab antibody Mabtech do not coincide with lysosomes in the AD fly models. Drosophila
brain sections (day 21), of control, Ab1–42 9 2, AbPP and AbPP-BACE1 flies were costained with a Drosophila anti-LAMP1 antibody (green;
lysosomal marker), to investigate the presence of lysosomes, and the AbPP/Ab antibody 4G8 (red) (A–D) or with the N-terminal Ab antibody
from Mabtech (red) (E–H). DAPI was used to visualize cell nuclei (blue). Micrographs were taken at 1009 magnification, scale bar = 20 lm
and n = 6.
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could be due to intracellular Ab that disrupts mito-
chondrial function, leading to increased oxidative
stress and eventually apoptosis. This can explain how
a relatively low level of Ab1–42 may induce neurode-
generation.
Another early event in AD pathology includes
abnormalities in the endo-lysosomal pathway [30]
where increased levels of rab5 and rab7 proteins,
markers for early and late endosomes, respectively,
have been found to be up-regulated in individuals with
MCI as well as in AD patients [32]. Ab has been
shown to accumulate in lysosomes, a pathogenic event
indicating a loss of lysosomal integrity and the ability
to degrade its material [51–54]. Endo-lysosomal path-
ways are essential in maintaining cellular homeostasis.
Dysfunction of this intriguing system has been sug-
gested to represent a converging mechanism for many
diseases involving neurodegeneration, including AD
[55]. Investigation of the endo-lysosomal system in the
two AD fly models revealed that Lamp1 mRNA was
increased in the AbPP-BACE 1 flies and decreased in
the Ab1–42 9 2 flies. The increased Lamp1 mRNA
level in the AbPP-BACE flies is in line with previous
studies where increased lamp1 mRNA expression in
AbPPSL transgenic mice expressing AbPP with Swed-
ish and London mutations has been found [56]. These
data suggest abnormalities in the endo-lysosomal sys-
tem for both fly models that might contribute to the
toxicity in these flies. For the AbPP-BACE1 flies,
abnormality in the endo-lysosomal system may explain
toxicity despite the low level of Ab1–42 in these flies.
Indeed, small amounts of intracellular accumulation of
Ab in endocytic vesicles can trigger Ab oligomerization
[57], disrupting the vesicles’ ability to mature and lead-
ing to a decrease in protein degradation and eventually
inducing toxicity. For the Ab1–42 flies, the toxicity may
be caused by the down-regulation of lysosomes result-
ing in the lysosome machinery being overwhelmed by
Ab species and consequently leading to neuronal
death.
BACE1 is able to cleave AbPP at the plasma
membrane, but more frequently, BACE1 cleavage
occurs in the early endosomes resulting in the pro-
duction of C99 [58]. Interestingly, Ab is not the only
cleavage product from AbPP processing known to
cause endosomal dysfunction; C99 produced from
BACE1 cleavage of AbPP has been shown to patho-
logically activate rab5, leading to an accumulation of
swollen endosomes [8]. In both the AbPP and AbPP-
BACE1 flies, the signal for the AbPP/Ab antibody
(4G8) was detected in close vicinity with Drosophila
endosomes. Interestingly, the coincidence of these sig-
nals was distributed in different areas within the two
flies. In the AbPP flies, the area where the 4G8 and
endosome signals coincide is located distinctly from
the cell nuclei in the axons, while in the AbPP-
BACE1 flies, the 4G8 and endosome signals were
strongly clustered around the cell nuclei as well as in
the axons. The Mabtech signal (specific for the Ab
peptide) in the AbPP-BACE1 flies did not coincide
with the endosome staining, suggesting that the 4G8
signal in the AbPP-BACE1 flies corresponds to either
full-length AbPP or C99. The increase in the C99
level detected for the AbPP-BACE1 flies compared to
the AbPP flies suggests that the 4G8 staining around
the cell nuclei in the AbPP-BACE1 flies corresponds
to accumulation of C99 while the 4G8 staining visi-
ble in the axons of the AbPP-BACE1 flies and the
AbPP flies corresponds to full-length AbPP. Thus,
the high level of C99 detected for the AbPP-BACE1
flies that coincided with endosomes, together with the
increased amount of apoptotic cells identified in these
flies, compared to the AbPP flies, suggests that a
possible contributor to the apoptosis in the AbPP-
BACE1 flies is the accumulation of C99 in endoso-
mal vesicles. This may lead to a disruption in the
endosomal pathway that will decrease the ability of
the neurons to degrade or recycle proteins, thereby
leading to apoptosis [26]. In the Ab1–42 9 2 flies, the
4G8 and Mabtech signals did not coincide with
either endosome or lysosome markers, despite being
in close proximity to the cell nuclei. Hence, if these
species, detected by 4G8 and Mabtech antibodies, are
located intracellularly, they are generally not associ-
ated with endosomes or lysosomes. Another possibil-
ity is that the 4G8 and Mabtech signals in the Ab1–
42 9 2 flies are detecting aggregated extracellular Ab
species. Indeed, both the 4G8 and Mabtech antibod-
ies have been documented to detect not only mono-
meric Ab but also oligomers and larger aggregated
species [33].
Taken together, in this study we have identified pos-
sible toxic mechanisms in two distinct AD fly models;
high levels of Ab1–42 correlate with a high number of
apoptotic cells in the Ab1–42 9 2 flies, which also dis-
plays increased protein carbonylation indicating oxida-
tive stress. In addition, the lysosomal machinery was
found to be slightly down-regulated in the Ab1–42 9 2
flies which can contribute to the pathological events
detected in this model. In the AbPP-BACE1 flies, a
considerable amount of apoptotic cells was detected,
and these flies also display increase in protein carbony-
lation, representative of oxidative stress. However, it is
unlikely that the small amount of Ab1–42 detected is
solely responsible for the cell death in these flies. Possi-
ble contributors to the toxicity in the AbPP-BACE1
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flies are an increased level of intracellular C99 and
abnormalities in the endo-lysosomal system.
Notably, this study highlights the versatility of these
fly models and how they can be used to increase our
understanding of the mechanisms underlying AD. Fur-
thermore, taken together, these AD fly models present
a possibility to investigate potential treatment strate-
gies that target Ab production and Ab aggregation but
also other cellular events closely linked to the disease,
for example oxidative stress and dysfunction in the
endo-lysosomal pathway.
Materials and methods
Drosophila stocks
The Gal4/UAS system was used to achieve a tissue-specific
protein expression in UAS transgenic D. melanogaster [59].
Elav-Gal4 flies were used as the driver line. This allows
expression in the CNS and the PNS, in developing neuronal
cells and in early glial cells of the flies. Control w1118 flies (only
expressing Gal4) were used as a control for the Ab1–42 9 2
flies, and a fly line expressing Gal4 and human AbPP was used
as a control for the AbPP-BACE1 flies. The AbPP-BACE1 fly
model has previously been described [14]. Ab1–42 flies were
kindly provided by D. Crowther (AstraZeneca, Floceleris,
Oxbridge Solutions Ltd.). These Ab flies produce an aberrant
Ab42 peptide with additional N-terminal glutamine residue
[19]. A fly line containing double copies of signal peptide
Ab1–42 (Ab1–42 9 2 flies) was generated as previously
described [48]. The fly lines were not backcrossed prior to the
experiment. Fly crosses were set up at 18 °C at 60% humidity
with 12:12-h light:dark cycles. For all biochemical assays, flies
were aged for 21 days at 29 °C and then snap-frozen or
embedded in Tissue-Tek OCT Compound (25608-930; VWR,
Stockholm, Sweden).
Samples preparation and protein quantification
of Ab1–42
For the analysis of total Ab1–42, a multispot 96-well V-PLEX
human Ab1–42 kit plate (K151LBE-1; Meso Scale Discovery,
Rockville, MD, USA) was used. Samples were prepared, and
quantification was carried out as previously described in Ref
[14]. In short, approximately 20 fly heads or bodies were
homogenized in 25 lL extraction buffer [50 mM HEPES,
5 M guanidinium chloride, 5 mM EDTA, 1 9 protease inhi-
bitor (cOmplete EDTA-free Protease Inhibitor Cocktail
Tablets; Roche Diagnostics, Basel, Switzerland)], for extrac-
tion of both insoluble and soluble Ab1–42 species. After cor-
recting total protein concentration in each sample due to
differences in the homogenization step using the Bio-Rad
DC Protein Assay Kit II (500-0112; Bio-Rad, Hercules, CA,
USA), protein samples were added to the wells of a multispot
96-well V-PLEX human Ab1–42 kit plate. The assay was then
carried out according to manufacturer’s instructions.
TUNEL assay
OCT blocks with embedded fly heads were sectioned using
a Microm HM550 Cryostat (Microm International GmbH,
Dreieich, Germany) into 20-lm-thin sections and stored at
20 °C until use. The TUNEL assay was performed using
FragELTM DNA Fragmentation Detection Kit, Fluorescent
– TdT Enzyme (QIA39; Merck Millipore, Burlington, MA,
USA). The assay was carried out as per the manufacturer’s
instructions; however, the incubation time with proteinase
K was set to 2 min and the sections were allowed to incu-
bate with the TdT enzyme for 60 min at 37 °C. The slides
were analysed using a Zeiss LSM 780 confocal microscope
(Zeiss, Oberkochen, Germany). Micrographs were pro-
cessed in Adobe Photoshop (Adobe Systems, San Jose, CA,
USA); background levels were reduced, and the signal
levels were enhanced. All images were treated identically.
For each genotype, four to five brain sections correspond-
ing to the medulla and lamina were scored in a nonbiased
fashion. The scoring system ranged from 0 (no TUNEL-
positive cells), 1 (a few TUNEL-positive), 2 (more
TUNEL-positive cells, but still a lot of TUNEL-negative
cells), 3 (approximately 50% TUNEL-positive cells) to 4
(more TUNEL-positive cells than TUNEL-negative cells).
The data were plotted and analysed using GRAPHPAD PRISM
7 (San Diego, CA, USA). To identify any significant differ-
ence between the groups, a one-way ANOVA followed by
Tukey’s post hoc test was performed.
qPCR analysis
w1118, Ab1–42 9 2, AbPP and AbPP-BACE1 flies were col-
lected and stored at 80 °C. Total RNA was extracted using
the RNeasy Micro Plus Kit (Qiagen, Caldwell, ID, USA).
The A260/A280 was determined to be above 2.0 on a Nano-
Drop ND2000 UV-vis Spectrophotometer (Labtech Interna-
tional Ltd., Uckfield, UK), and the RNA integrity was
confirmed on a 1% agarose gel showing a single
band ~ 2.0 kbp in size, representative of the 18S rRNA and
the 28S rRNA (which, in Drosophila, is cleaved into two
fragments that migrate at the same position as the 18S
rRNA) [60]. cDNA was synthesized using the RNA samples
and the ImProm-IITM Reverse Transcription System (Pro-
mega UK Ltd., Southampton, UK). qPCR primer sequences
for the Drosophila genes, rab5 and lamp1, and the reference
genes, gapdh2 and aTub84B, were previously published [61].
Standard curves for all four genes were generated using
cDNA concentrations of 0.04, 0.2, 1, 5 and 25 ng and per-
forming standard qPCRs under the experimental conditions:
a 20 lL reaction included 0.2 lM primers (Sigma-Aldrich),
Fast SYBR Green Master Mix (Thermo Fisher Scientific,
Waltham, MA, USA), cDNA (ranging 0.04–25 ng per well)
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and dH2O. Efficiency of all reactions was found to be
between 90 and 110%, and therefore, the use of the compara-
tive CT method for data analysis was applied [62]. Reactions
were performed in a StepOnePlus Real-Time PCR System
(Applied Biosystems Ltd., Foster City, CA, USA). Each well
included: 0.2 µM primer, 2.5 ng cDNA and 19 Fast SYBR
Green Master Mix; each sample was analysed in duplicate.
Reactions were performed with an initial denaturation
(95 °C, 10 min), followed by 42 cycles of denaturation
(95 °C, 15 s), annealing and extension (60 °C, 1 min). Melt-
ing curves were monitored between 60 °C and 95 °C. Prod-
ucts were checked by electrophoresis on a 2% agarose gel to
verify the presence of one single band (amplicon) with a cor-
rect product size. Data were collected from three indepen-
dent batches (n = 3) of flies (20 flies in each repeat). The
qPCR results from multiple runs were analysed using the
comparative CT method [62]. The change in expression of the
two target genes (rab5 and lamp1) in AbPP-BACE1
(Ab1–42 9 2) was determined relative to the appropriate con-
trol sample, that is AbPP (w1118), and presented as mRNA
fold change. Wilcoxon signed-rank test was used to test sta-
tistical significance.
Immunohistochemistry
OCT blocks with embedded fly heads were sectioned as
described above. The sections were fixed with 4% (w/v) PFA
for 10 min at RT and then washed 3 9 3 min with PBS-T.
Additional permeabilization of the sections was carried out
using 0.5% Tween-20 for 10 min at RT. The washing step
was repeated, and the sections were blocked for 60 min at
RT using 10% BSA in PBS-T. After blocking, the sections
were incubated with the primary antibodies, 4G8 (SIG-
39220; BioLegend, San Diego, CA, USA); anti-human Amy-
loid-b mAb Abeta (3740-5-250; Mabtech); anti-rab5 anti-
body (ab31261; Abcam, Cambridge, UK); anti-LAMP1
antibody (ab30687); anti-axons antibody (ab12455), all
diluted 1 : 500 in 1% BSA in PBS-T, incubated overnight at
4 °C. After repeating the washing step, the sections were
incubated with secondary antibodies goat anti-mouse Alexa
594 (R37121; Thermo Fisher Scientific) and goat anti-rabbit
Alexa 488 (R37116; Thermo Fisher Scientific), diluted
1 : 500 in 1% BSA for 60 min at RT. After a final washing
step, the sections were rinsed with dH2O and left to dry
before mounting them with VECTASHIELD DAPI (H-
1200; Vector Laboratories, Burlingame, CA, USA). The
slides were analysed using a Zeiss LSM 780 confocal micro-
scope. Micrographs were processed in Adobe Photoshop;
background levels were reduced, and the signal levels were
enhanced. All images were treated identically.
Protein carbonylation assay
The heads of snap-frozen flies (20 flies/genotype) were
homogenized in 25 lL RIPA lysis and extraction buffer
(89900; Thermo Fisher Scientific) with 19 Protease Inhibi-
tor (cOmplete EDTA-free Protease Inhibitor Cocktail
Tablets; Roche Diagnostics) and 50 mM dithiothreitol.
After centrifuging the samples for 10 min at 18 928 g, the
supernatant was collected and the total protein level
extracted was determined using a Bio-Rad DC Protein
Assay Kit II (500–0112; Bio-Rad). Samples were prepared
to have a final protein concentration of approx.
30 mgmL1. The sample preparation was then divided into
two Eppendorf tubes, where derivatization of the carbonyl
groups was carried out using the OxyBlot Protein Oxida-
tion Detection Kit (S7150; Merck, Kenilworth, NJ, USA)
according to the manufacturer’s instructions on one half of
the sample. The other half was used as a negative control,
where derivatization-control solution (S7150; Merck) was
added instead of DNPH solution (S7150; Merck). Gel elec-
trophoresis was performed using Bolt 4–12% Bis-Tris Plus
Gels (NW04120BOX; Life Technologies, Carlsbad, CA,
USA). Transfer was performed using an original iBlot Gel
Transfer Device from Life Technologies onto PVDF mini
membranes (IB401002; Life Technologies). The membrane
was blocked using 10% BSA for 1 h at RT. The primary
antibody (rabbit anti-DNP antibody, 90451; Merck) was
prepared diluted 1 : 150 in 1% BSA and added to the
membrane for 1 h, RT. This was followed by a washing
step, 3 9 3 min with PBS-T before adding the secondary
antibody (goat anti-rabbit, HRP-conjugated, 90452; Merck)
for 1 h, RT, diluted 1 : 300 in 1% BSA. The washing step
was repeated before incubating the membrane with Clarity
Western ECL Substrate (1705060S; Bio-Rad) for 5 min
before imaging on a ImageQuant LAS 4000 (GE Health-
care Life Sciences, Marlborough, MA, USA). Bands from
the nonderivatized negative control sample preparation that
appears in all samples were used as a loading control.
Western blot analysis
Protein extract from fly heads was obtained as described
above. Samples of approximately 5 µg) were loaded onto a
Bolt 12% Bis-Tris Plus Gel and after protein separation by
electrophoresis transferred onto a nitrocellulose membrane.
The membrane was boiled for 5 min in PBS and thereafter
blocked in 5% milk in TBS-Tween. Immunodetection was
performed with monoclonal primary antibodies: anti-C-ter-
minal AbPP (A8717, 1 : 8000; Sigma-Aldrich) and anti-
tubulin (loading control; ab7291; 1 : 2000; Abcam)
followed by HRP-conjugated corresponding secondary anti-
bodies (Dako, Santa Clara, CA, USA). Densitometric anal-
ysis was performed on four separate blots using IMAGEJ
1.50i (Wayne Rasband, National Institutes of Health,
Bethesda, MD, USA). Bands corresponding to full-length
APP and the C-terminal cleavage fragment (CTF) were
normalized to tubulin expression. Statistical analysis was
performed using the Mann–Whitney U test. Differences
were considered significant when P ≤ 0.05.
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